Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Clinically validated examples of in silico and structure-based approaches contributing directly to approved therapeutics include the development of HIV protease inhibitors in the 1990sthe first drugs designed using computational structureactivity relationshipsand the more recent application of GPCR crystal structures to guide ligand optimization for receptors, including the 2-adrenoceptor and GLP-1 receptor (Kobilka and Deupi, 2007
Structure or function claims must include the required DSHEA disclaimer
Obesity affects more than one-third of Americans
Coagulation abnormalities and ivermectin
R., Huerta-Yepez, S
US$ 26.09
US$ 24.38
US$ 24.60
US$ 26.72
